Xanomeline + Trospium Chloride Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 50mg+20mg, 100mg+20mg, 125mg+3
Reference Brands: Cobenfy (USA)
Category:
Neurology
Cobenfy is a novel oral combination of xanomeline (a muscarinic receptor agonist) and trospium chloride (an antimuscarinic agent that limits side-effects). It is approved for the treatment of schizophrenia in adults, offering a new mechanism of action distinct from traditional dopamine-blocking antipsychotics. The treatment is taken twice daily as capsules on an empty stomach. Common side effects include nausea, dyspepsia, constipation, vomiting, hypertension, and tachycardia.
Xanomeline + Trospium chloride is available in Capsules
and strengths such as 50mg+20mg, 100mg+20mg, 125mg+3.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Xanomeline + Trospium chloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Xanomeline + Trospium chloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing